Progression through the cell cycle is dependent on the sequential expression of cyclins, which combine with cyclin-dependent kinases (cdks) to form active kinases. The transition from G 1 to S phase is dependent on D cyclins in complex with cdk4 or cdk6 and cyclin E complexed with cdk2. One target of G 1 cyclins is the retinoblastoma susceptibility protein (Rb). Rb is a transcriptional repressor that is selectively targeted to genes through interaction with the E2F family of cell cycle transcription factors. Rb is a member of a family of proteins that include p107 and p130. The three proteins share a region known as the pocket that is important for binding E2F and is also the binding site for oncoproteins from DNA tumor viruses that inactivate Rb. We have found that two conserved domains within the Rb pocket (A and B) interact to form a transcriptional repressor motif (K. N. B. Chow and D. C. Dean, Mol. Cell. Biol. 16: [4862][4863][4864][4865][4866][4867][4868] 1996). Here we demonstrate that p107 also has an A-B repressor motif, and using domain swapping and coimmunoprecipitation assays, we compare A and B from Rb and p107. Finally and most importantly, we demonstrate that the A-B interaction which forms the repressor motif is blocked by G 1 cdk phosphorylation, thereby blocking repressor activity. This A-B repressor motif is then the first example of a cdk-regulated transcriptional repressor.
Progression through the cell cycle is regulated by the sequential appearance of cyclins, which function as regulatory subunits of cyclin-dependent kinases (cdks) (62) . The transition from G 1 to S phase is regulated by D cyclins (D1, D2, and D3) in complex with cdk4 or cdk6 (5, 47, 50, 51) and cyclin E in complex with cdk2 (17, 41) . Active complexes of D and E cyclins are apparent in mid to late G 1 (48, 62) . Microinjection of antibodies to cyclin D1 or antisense mRNA expression vectors prevent the G 1 -to-S transition (4, 57) , and overexpression of cyclin D1 or E shortens G 1 (3, 37, 40, 53, 57, 58, 72) . Likewise, antibodies to cdk2 or expression of a dominant negative form of cdk2 blocks entry into S phase (66) .
One target of G 1 cdks appears to be the retinoblastoma susceptibility protein (Rb) (11, 30, 31, 63) . Rb is phosphorylated initially during mid G 1 , and it becomes hyperphosphorylated as the cell cycle progresses until it is dephosphorylated at the end of mitosis (8, 9, 15, 46, 51) . These phosphorylation sites fit the cdk consensus sequence (43, 45) , and various different cdks have been shown to phosphorylate Rb in vitro (2, 21, 33, 40, 43, 45, 47, 48) . Likewise, overexpression of cyclins A, D, and E have been shown to cause inactivating phosphorylation of Rb in transfection assays (1, 21, 29, 67) . Even though overexpression of D cyclins or cyclin E can cause inactivating phosphorylation of Rb, there is mounting evidence that cyclin D-cdk complexes normally target Rb for inactivating phosphorylation in vivo, whereas cyclin E-cdk2 has an additional cellular target (59, 61) .
Rb functions as a transcriptional repressor. In its hypophosphorylated form, Rb binds to members of the E2F family of cell cycle transcription factors during G 1 (54) . This interaction blocks E2F activity and serves to recruit a dominant acting repressor motif in Rb to the promoter of genes containing E2F sites that are required for cell proliferation (1, 7, 26, 67, 69) . In response to phosphorylation in mid to late G 1 , Rb dissociates from E2F and genes with E2F sites are activated, leading to progression of the cell from G 1 to S phase (42, 54) .
Rb is a member of a family of proteins that include p107 and p130 (12, 20, 27, 44, 49) . Although p107 and 130 have not yet been found to be mutated in tumors, like Rb they appear to be involved in cell cycle regulation. Members of the Rb family share a conserved motif that was originally termed the pocket because of its interaction with oncoproteins from several different DNA tumor viruses (14, 18, 19, 22, 32, 34, 35, 38, 71) . The pocket consists of two domains, A and B, that show conservation among the family members; these domains are separated by a nonconserved spacer that varies in length (12, 20, 27, 44, 49) . The domains in p130 and p107 are more similar to each other than to corresponding domains of Rb (12, 27, 44, 49) .
We have found that A and B are sufficient for the dominant repressor activity of Rb (67) and that the repressor motif is formed by the interaction of A with B (10). A and B can reform the repressor motif when they are coexpressed on separate proteins, and mutations that disrupt the interaction also block repressor activity. Additionally, we found that the interaction between A and B forms the adenovirus E1a binding site and that the binding of E1a to this site appears to clamp A and B together and stabilize the complex.
Here we extend our studies of the A-B repressor motif by demonstrating that the A and B domains of p107 interact to form a similar repressor motif, and using domain swapping experiments, we show that A and B from Rb and p107 are at least partially functionally conserved. Finally and most importantly, we demonstrate that G 1 cdk phosphorylation disrupts the A-B interaction (and thus repressor activity), making this A-B motif the first example of a cdk-regulated transcriptional repressor.
MATERIALS AND METHODS
Transfection assays. DNA was transfected into C33A cells by the calcium phosphate method, and chloramphenicol acetyltransferase (CAT) activity was determined as described previously (69) . TKluc (0.5 g) was cotransfected, and luciferase assays were done to correct for transfection efficiencies as described previously (67) .
Plasmids. Rb fusion proteins with Gal4 and LexA have been described previously (10). pCMV107 and p107C768 have been described previously (75) . The Gal4 sequence from pM3 was removed by digestion with BamHI and BglII and cloned into the BamHI site of pCMV107 to create G-107. G-107-1-768 was created in the same fashion by cloning the Gal4 sequence into p107C768. G-107P (amino acids [aa] 385 to 949) was created by first replacing the DraIII-EcoRI fragment in GST107A/B-RBS (where RBS stands for Rb spacer) (20) with a p107 spacer fragment (DraIII-EcoRI), removing the pocket with BamHI, and cloning it into the BamHI site of pM2. G-107S (aa 577 to 786) was created by removing the spacer from GST-p107S (19) with BamHI and cloning it into the BamHI site in pM2. G-107A was made by cloning the BamHI-HindIII fragment from GST107A/B-RBS into the BamHI and HindIII (partial digest) of G-107S. G-107B was made by removing B from GST107A/B (20) with BglII and BamHI and was used to replace the spacer in the BamHI site of G-107S. All constructs made by PCR or involving blunt-end ligations were sequenced.
Coimmunoprecipitation and Western blotting. Five micrograms each of the indicated expression vectors was cotransfected into C33A cells. After 36 h, cells were suspended in lysis buffer (50 mM HEPES [N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid; pH 7.0], 1 M NaCl, 0.1% Nonidet P-40, 1 mM dithiothreitol, 1 mM EDTA 0.01% phenylmethylsulfonyl fluoride) and subjected to mild sonication. The cleared lysate was immunoprecipitated with a monoclonal antiGal4 antibody (Santa Cruz) (used at 1.5 g/ml) and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on a 15% polyacrylamide gel. Proteins were Western blotted (immunoblotted) with a polyclonal anti-LexA antibody (R. Brent, Massachusetts General Hospital) or a monoclonal anti-E1a antibody (Oncogene Science) as described previously (67) .
Protease digestion and in vitro phosphorylation. To show that A and B interact in the context of the Rb molecule, 10 g of GSTRb-379-792 purified from bacteria was first digested with a low concentration of thrombin (0.1 NIH unit of thrombin for 3 h at room temperature) in 50 mM Tris (pH 7.5)-150 mM NaCl-2.5 mM calcium chloride to cleave the thrombin-sensitive site between Rb and glutathione S-transferase (GST). GST was then removed by glutathione beads. The purified Rb fragment was then digested with a higher concentration of thrombin (1 NIH unit for 3 h), which cleaves a less-sensitive thrombin site in the spacer between A and B. The cleaved A and B were then immunoprecipitated overnight with a domain A-specific monoclonal antibody (14441A from PharMingen) or a control antibody (monoclonal antibody against TAF250 from Santa Cruz). The immunoprecipitates were then Western blotted with a domain B-specific monoclonal antibody (MAb6 from Oncogene Science). For the in vitro phosphorylation study, 0.5 g of GSTRb-379-928 purified from bacteria or 0.1 g of His-Rb (full length) purified from baculovirus-infected insect cells (courtesy of S. Dowdy) was divided into two halves. The first half was digested with thrombin (0.25 NIH unit for 3 h) or trypsin (0.01 g for 1 h), respectively. The second half was mixed with human GST-cyclin A-cdk2 complex expressed and purified from baculovirus-infected insect cells (courtesy of H. Piwnica-Worms) in an in vitro phosphorylation assay as described previously (73) . The phosphorylation status of GSTRb-379-928 and His Rb (full length) was confirmed by resolving them on an 8% polyacrylamide gel and looking for a decrease in mobility associated with the hyperphosphorylated form. The phosphorylated The p107 pocket blocks E2F activity. pTA-E2F-CAT (0.5 g) (69) was transfected into C33A cells along with 0.25 g of the indicated expression vectors, and CAT activity was analyzed as described in Materials and Methods. (C) Domains A and B of p107 interact at the promoter to block E2F activity, and E1a blocks this activity. E1a indicates cotransfection of 0.25 g of an expression vector for a deletion of aa 2 to 36 of E1a, which removes the repressor domain leaving the p107 binding site intact (13, 36, 52) . (D) A and B from p107 interact to form a general repressor. pSVEC-G or pSVEC (0.25 g) was cotransfected with 0.5 g of the indicated expression vector into C33A cells as described for panel B. pSVEC-G (10) contains Gal4 sites upstream of the simian virus 40 enhancer and E1b TATA box driving the CAT gene. (E) Domains from Rb and p107 interact to form a repressor. pSVEC-G was cotransfected with the indicated expression vectors. G-Rb-A is G-379-602, G-Rb-B is G-620-792, and G-Rb-C is G-767-928 (numbers indicate amino acids in Rb [10] ). p107 constructs are described in Materials and Methods. Results are averages of duplicate assays and are representative of more than three separate experiments.
proteins were then digested with thrombin or trypsin as described above. Finally, protease-treated samples were resolved on a 15% polyacrylamide gel, transferred to nitrocellulose, and Western blotted with domain A-and domain Bspecific monoclonal antibodies (14041A from PharMingen for A and MAb6 from Oncogene Science for B) as described previously (67) .
RESULTS
p107 contains an A-B repressor motif similar to that found in Rb. We have demonstrated that domains A and B in the Rb pocket interact to form a transcriptional repressor motif (10, 67) . Like Rb, the Rb-related protein, p107, can bind E2F (6, 24, 25, 60) and E1a, and these interactions are dependent on a region of p107 showing sequence similarity to the Rb pocket (22, 75) . There are two sequences within this region that show similarity to those of A and B and are similarly separated by a spacer (Fig. 1A) . However, the spacer in p107 is larger than that in Rb and shows no similarity to the Rb spacer, and it has been implicated in binding to cyclin A (20, 23) . Although p107
has not yet been found to be mutated in tumors, its overexpression in cells also leads to growth suppression (64, 74, 75) . These similarities in activity between Rb and p107 along with the sequence similarity in p107 to domain A and B of the Rb VOL. 16, 1996 A CONSERVED cdk-REGULATED REPRESSOR MOTIF 7175 pocket suggested that the repressor motif formed by the A-B interaction in Rb may be shared by p107. In transfection assays with the Rb Ϫ cervical cancer cell line C33A (similar results were seen with other Rb Ϫ and Rb ϩ cell lines [results not shown]), p107 blocked E2F activity in a minimal reporter construct containing E2F sites upstream from the E1b TATA box (pTA-E2F-CAT) (68) as demonstrated previously (42, 54) ; the pocket was sufficient for full inhibitory activity (Fig. 1B) (65) . As with Rb, when other enhancers were present on the promoter, p107 had a dominant inhibitory effect on transcription when tethered to the promoter through E2F (i.e., it blocked the activity of the surrounding enhancers) (65) . Coexpression of A and B from the p107 pocket on separate proteins blocked E2F activity, and this activity was disrupted by coexpression of adenovirus E1a with a deletion of aa 2 to 36, which removes the repressor domain of E1a but leaves the p107 binding site intact (52) (Fig. 1C) . Likewise, coexpression of Rb-A and Rb-B plus the C-terminal region of Rb (C) also blocked E2F activity. When p107-A was coexpressed with Rb-BC, E2F activity was also blocked, suggesting that this combination of fragments from the two proteins can cooperate to inactivate E2F. However, the combination of Rb-A plus p107-BC did not block E2F activity.
A and B from p107 also had a dominant inhibitory effect on transcription when they were coexpressed as separate fusion proteins with the DNA binding domain of the yeast transcription factor Gal4 along with the pSVEC-G reporter containing Gal4 binding sites upstream of the simian virus 40 enhancer and E1b TATA box (10, 69) (Fig. 1D) . As with the simian virus 40 enhancer and E2F sites, G-107 also inhibited the cytomegalovirus promoter and the herpes simplex virus thymidine kinase promoter when Gal4 sites were placed upstream (results not shown). Western blots of Rb and p107 fusion proteins expressed in transfected C33A cells showed that the proteins were expressed at similar levels and had the expected sizes (10, 65) . Taken together, the above results suggest that p107 contains an A-B repressor motif similar to the one found in Rb. FIG. 4 . A and B interact in the context of Rb. GST-379-792 (39) (A and B along with the spacer) was purified from bacteria with glutathione beads as described previously (67) . A low concentration of thrombin was used to remove the GST sequence, and then the purified Rb fragment was digested with a higher concentration of thrombin which cleaves a less sensitive site in the Rb sequence, resulting in Rb fragments with sizes of 27 and 20 kDa. A Western blot of the digested fragments with a domain A-specific monoclonal antibody (14441A; Pharmigen) revealed that the 27-kDa fragment contains domain A. Stripping and reprobing the blot with a domain B-specific monoclonal antibody (MAB6; Oncogene Science) confirmed that the 20-kDa band contains domain B. (B) On the basis of the size of the fragments, the thrombin cleavage site is within the spacer. The thrombin-cleaved fragments were immunoprecipitated with the domain A-specific antibody, and the immunoprecipitated proteins were then probed with the domain B-specific antibody in a Western blot to assess the extent of A-B interaction. As a control, a monoclonal antibody against TAF250 (Santa Cruz) was used for immunoprecipitation. IgG-H and -L indicate the heavy and light chains of the antibodies, respectively, used for immunoprecipitation. A and B from p107 interact in vivo. We have found that A and B from Rb interact in vivo to form a repressor motif (10); the above-described results suggested that A and B from p107 may also interact. Therefore, coimmunoprecipitation assays were used to determine whether A and B from p107 can interact in vivo. For these experiments, expression vectors for p107 fragments fused to either the sequence encoding the DNA binding domain of Gal4 or the gene encoding the bacterial protein LexA were cotransfected into C33A cells. Cell lysates were divided into three parts, 10% was used for a direct Western blot for LexA fusion proteins, another 10% was used for direct Western blotting for Gal4 fusion proteins, and the final 80% was immunoprecipitated with a monoclonal antiGal4 antibody (Fig. 2 ). The immunoprecipitated proteins were then Western blotted with polyclonal anti-LexA antisera to detect an interaction between A and B. The results demonstrate that A and B associate efficiently and specifically.
A and B from Rb and p107 appear to be functionally interchangeable in transcriptional repression assays. To determine whether one domain from p107 can cooperate with a second domain from Rb to repress transcription, Gal4 fusion proteins expressing heterologous domains were transfected along with the pSVEC-G reporter. In contrast to inactivation of E2F (Fig.  1C) , the combination of both p107-A plus Rb-BC and Rb-A plus p107-BC repressed transcription when the proteins were targeted to the promoter through a Gal4 DNA binding domain (Fig. 1E) .
Heterologous domains from Rb and p107 can interact in vivo. Since domains from Rb and p107 can cooperate to form a repressor motif in transfection assays (Fig. 1) , and the interaction between A and B appears to be important for repressor activity, it seemed likely that A from Rb would interact with B from p107 and vice versa. Similar coimmunoprecipitations were then used to detect an interaction between domains from Rb and p107. The results suggest that heterogeneous domains from Rb and p107 interact as efficiently as the homologous domains from a single protein (Fig. 2) .
The A-B interaction mediates the formation of a cell growth suppressor. Although A and B of Rb are sufficient for transcriptional repressor activity when tethered to a promoter through Gal4 or LexA, cell growth suppression requires the large pocket (the C-terminal region of Rb in addition to A and B) (55, 56) . The large pocket appears to be required for growth suppression at least in part because the C-terminal region of Rb is necessary for efficient binding of Rb to E2F, which is normally critical for targeting the repressor activity of Rb to promoters. Additionally, the C-terminal region of Rb has been shown to interact with other proteins such as c-abl, which may also be important for cell growth suppression (70) .
To determine whether an interaction between A and B of
FIG. 6. Cdk phosphorylation regulates the A-B interaction. (A) Overexpression of G 1 cyclins blocks the A-B interaction in vivo.
Five micrograms each of G-1-621 and L-620-928 was cotransfected with 1 g of expression vectors for cyclins D1, E, or B (29) into C33A cells. In lanes labeled minus, 1 g of the parent cyclin expression vector was cotransfected. At 36 h after transfection, cell lysates were split into four parts and treated as indicated. Cyclins B and E were detected with antibodies from Santa Cruz (diluted 1:100), and cyclin D1 was detected with an antibody from PharMingen (diluted 1:2,000). Immunoprecipitations and Western blotting were done as described in the legend to Fig. 2. (B) Interaction of A and B alone is not affected by overexpression of G 1 cyclins. G-379-602 and L-620-792 were transfected along with G 1 cyclin expression vectors as described for panel A, and the A-B interaction was analyzed by coimmunoprecipitation (I.P.). (C) Overexpression of cyclin E does not affect repressor activity when A and B alone are coexpressed on separate proteins. The indicated expression vectors were cotransfected with the pSVEC-G reporter as described in the legend to Fig. 1 . Note that overexpression of cyclin E blocks repressor activity of the combination of A and B plus the C-terminal region but not of A and B alone, indicating that the presence of the C-terminal region allows overexpression of cyclin E to block repressor activity. I.P., immunoprecipitated; UT, untransfected cells. VOL. 16, 1996 A CONSERVED cdk-REGULATED REPRESSOR MOTIF 7177
on September 7, 2017 by guest http://mcb.asm.org/ Rb would mediate formation of a large pocket with cell growth suppressor activity, expression vectors for A and B plus the C-terminal region were cotransfected into the Rb Ϫ osteosarcoma cell line Saos-2, in which growth is suppressed by Rb (55, 56) . The repressor activity for Rb and p107 described above in C33A cells was also apparent in Saos-2 cells and all other cell lines that we examined (Rb Ϫ or Rb ϩ ) (results not shown). We found that, as with general repressor activity and inactivation of E2F, the A-B interaction was able to mediate formation of a growth suppressor (Fig. 3) . The cells in which growth was suppressed acquired the characteristic flat morphology seen when wild-type Rb is expressed in Saos-2 cells (results not shown). Unlike A and B, the C-terminal region of Rb does not function independently when it is expressed on a separate protein; it must be fused to domain B for activity. This is demonstrated by the finding that coexpressing (on separate proteins) the C-terminal region of Rb and the pocket does not lead to growth suppression (Fig. 3) .
Growth suppression by Rb is prevented by overexpression of G 1 cyclins, which leads to the constitutive hyperphosphorylation and inactivation of Rb (16, 21, 29, 67) . Therefore, it was of interest to determine whether overexpression of G 1 cyclins would also block the activity of the growth suppressor formed by the interaction of domains A and B of Rb. As stated above, since full-length Rb may be phosphorylated more efficiently, the N-terminal region of Rb was included with domain A and this protein was coexpressed with domain B plus the C-terminal region. This combination efficiently suppressed cell growth, and overexpression of G 1 cyclins prevented the activity; cyclin B had no effect (Fig. 3). (Expression of the cyclins in transfected cells is shown below in Fig. 6A.) We conclude that the A-B interaction can mediate formation of a cell growth suppressor that is similar to that found in wild-type Rb. Domains from Rb and p107 can combine to form a cell growth suppressor. Several distinct regions of p107 have been shown to have growth suppressor activity (64, 74) ; however, we found that the pocket is sufficient for most of the p107 growth suppressor activity (65) . Therefore, we asked whether domains from Rb and p107 could combine to form a growth suppressor in Saos-2 cells as described above (Fig. 3) . The results indicate that the combination of Rb domain B plus the C-terminal region with p107 domain A or A plus the N-terminal region resulted in growth suppression (Fig. 3) . However, as with inactivation of E2F (Fig. 1C) , the converse was not true-the combination of Rb domain A or A plus the N-terminal region with p107 domain B or B plus the C-terminal region did not suppress growth. We have demonstrated previously that coexpression of A and B domains of p107 on separate proteins results in growth suppression (65) . Taken together, our results suggest that the A-B interaction forms a repressor motif but that only the combination of p107-A and Rb-BC can also form a domain which binds and inactivates E2F. Additionally, we suggest that the combination of Rb-A and p107-BC is unable to suppress growth because the repressor domain formed by these fragments cannot be tethered to the promoter of cell cycle genes through an interaction with E2F.
A and B interact in the context of Rb. We have demonstrated that A and B can interact to form a repressor motif when they are coexpressed on separate proteins (10) . It was of interest to determine whether A and B actually interact in the context of Rb. To demonstrate such an interaction in the context of the Rb molecule, the pocket region of Rb (A and B along with the spacer region) was purified from bacteria and digested with thrombin. We found that overdigestion of the pocket with thrombin leads to a cleavage within the spacer between A and B, but otherwise the two domains remain intact (Fig. 4) . After thrombin cleavage, a domain A-specific antibody was used for immunoprecipitation, and a domain Bspecific antibody was then used to detect association between the domains in a Western blot of the precipitated proteins. We found that, even though the covalent linkage between A and B had been broken by thrombin digestion, all A and B domains were associated, suggesting that these two domains do indeed interact within the Rb molecule.
Phosphorylation of Rb by G 1 cdks results in an altered pattern of proteolytic cleavage in the pocket consistent with a phosphorylation-induced conformational change. It has been demonstrated previously that the spacer separating A and B in the Rb pocket as well as the region carboxy-terminal of the pocket (C-terminal domain) is sensitive to serine proteases such as trypsin, whereas A and B are relatively resistant (28) . We confirm the protease-resistant nature of A and B after proteolytic digestion of the Rb large pocket (pocket plus the C-terminal region [aa 379 to 928]) followed by Western blotting with antibodies specific for A or B (Fig. 5) . The large FIG. 7 . In vitro phosphorylation of B plus the C-terminal region by cyclin E-cdk2 inhibits binding of domain A. (A) Diagram of experiment. GST-BϩC bound to glutathione beads was phosphorylated in vitro with baculovirus-expressed cyclin E-cdk2 as described in the legend to Fig. 5 . GST-BϩC on beads was allowed to bind GST-A (GST was removed from A by thrombin digestion as described in the legend to Fig. 4) ; the beads were spun down and washed as described previously (67) . GSH, glutathione. (B) A Western blot was used to determine the amount of A that bound to GST-BϩC as described in the legend to Fig. 4 . on September 7, 2017 by guest http://mcb.asm.org/ pocket was then phosphorylated with cyclin A-cdk2 or cyclin E-cdk2 purified from baculovirus. The characteristic decrease in electrophoretic mobility was observed following this phosphorylation (Fig. 5A ). When phosphorylated Rb was treated with protease under conditions identical to those used for unphosphorylated protein, A and B were digested, suggesting a phosphorylation-induced conformational change resulting in protease sensitivity. Digestion of Rb with a mutation at aa 706 which blocks pocket function, also did not result in proteaseresistant domains (results not shown), suggesting that as with phosphorylation, the aa-706 mutation disrupts pocket structure. G 1 cdk phosphorylation disrupts the A-B interaction and thus repressor activity. To determine whether phosphorylation disrupts the interaction between A and B, an expression vector for the G 1 cyclins, cyclin E and cyclin D1, or the control cyclin B was cotransfected into C33A cells along with Gal4-domain A plus N-terminal (Rb aa 1 to 621) region and LexAdomain B plus the C-terminal (Rb aa 646 to 928) region. Expression of cyclin E and D1 inhibited the A-B interaction, whereas there was no effect with cyclin B (Fig. 6A) . Accordingly, we have shown in this study and in another study (10) that overexpression of G 1 cyclins blocks repressor activity (Fig.  1B ) and growth suppression (Fig. 3 ) when A and B are coexpressed on separate proteins; cyclin B has no effect. Western blotting indicates that similar levels of the cyclins are expressed in the transfection assays and that the cyclins have no effect on expression of the Rb domains (Fig. 6A) . It is unclear which cyclin-cdk complex actually phosphorylates Rb in vivo. However, there is significant evidence of a role for both cyclin D and E associated kinases in this process. A previous study suggested that overexpression of cyclin E but not D1 could block repression by Rb (7); however, we found that overexpression of either of these cyclins catalyzed inactivating phosphorylation of Rb.
As a control, the effect of overexpression of G 1 cyclins on the interaction of A and B alone, which lack the sites for inactivating phosphorylation, was examined. Overexpression of cyclin E or D1 did not have any effect on the A-B interaction (Fig. 6B) . Likewise, overexpression of these cyclins did not block repressor activity (Fig. 6C) . When domain B plus the C-terminal region was phosphorylated in vitro with cyclin Ecdk2, interaction with domain A was inhibited (Fig. 7) , suggesting that phosphorylation of sites in the C-terminal region can regulate the A-B interaction. Likewise, inclusion of the C-terminal region with B rendered the repressor motif formed with domain A sensitive to overexpression of G 1 cyclins (Fig.  6C) .
Taken together, our results suggest that A and B interact to form a novel cdk-regulated repressor motif that serves as a checkpoint controlling the transition from G 1 to S phase in cells (Fig. 8) and that this motif is shared by the Rb family of proteins. Additionally, we present evidence that phosphorylation of the C-terminal region of Rb may regulate the A-B interaction.
DISCUSSION
Here we present evidence that the A-B repressor motif is conserved among Rb family members. Although there was little structural or mechanistic information available when the term pocket was first used to refer to the region of Rb containing A and B (38), our results demonstrating that an interaction between A and B is required for function suggest that the use of this term is indeed appropriate. Additionally, we present evidence that phosphorylation by G 1 cdks regulates the A-B interaction forming the repressor. Thus, this A-B motif is the first example of a cdk-regulated repressor.
The A-B interaction forms a repressor that can bind and inactivate transcription factors such as PU.1, Elf-1, and c-Myc when this motif is tethered to a promoter (10, 67) . However, this motif alone does not interact efficiently with E2F, and it is not sufficient for cell growth suppression (at least in part because it cannot be targeted to promoters through an interaction with E2F). It is clear that E2F and its binding partner DP-1 interact with a site on Rb different from that of other transcription factors that bind the pocket repressor motif (i.e., PU.1, Elf-1, and c-Myc) (67) . Such distinct binding sites appear critical for Rb function, allowing Rb to be tethered to promoters through E2F while simultaneously interacting with and inhibiting surrounding transcription factors (67) . We then conclude that the interaction between A and B results in formation of at least two distinct sites for protein binding in Rb: a binding site for E2F, requiring the C-terminal region (critical for targeting Rb to promoters), and a site(s) entirely within A and B that binds other transcription factors (critical for dominant negative activity).
Although domains A and B from Rb and p107 appear to be functionally interchangeable in the formation of a transcriptional repressor motif, we found that these interactions do not necessarily lead to formation of a growth suppressor. While domain A of p107 can interact with Rb domain B plus the C-terminal region to suppress cell growth, the converse is not true. Even though Rb domain A can interact with p107 B plus the C-terminal region to form a transcriptional repressor, this repressor does not suppress growth. One explanation for this lack of growth suppressor activity appears to be due to the inability of this combination to inactivate E2F. Taken together, our results suggest that while Rb-A and p107-BC can interact to form a repressor motif, this combination of fragments does not interact with E2F and therefore cannot be targeted to the proper set of cell cycle genes. It is likely that varying combinations of pocket protein domains may prove useful in analyzing protein-specific functions.
The C-terminal region of Rb may have a role in regulating the interaction between A and B. Phosphorylation of A and B alone did not disrupt repressor activity nor did it disrupt the A-B interaction in vitro. In contrast, when the C-terminal region of Rb was included along with B (B plus C-terminal region) phosphorylation disrupted the A-B interaction and prevents repressor activity. One interpretation of these results is that the C-terminal region somehow regulates the A-B interaction in response to phosphorylation. This raises the interesting mechanistic question of how phosphorylation of a region outside of A and B, which is not itself required for the A-B interaction, could lead to disruption of the A-B complex. One possibility is that a conformational change in the C-terminal region as a result of phosphorylation translates into structural alterations in adjacent sequences in B and/or A that prevent interaction. Alternatively, a phosphorylated C-terminal domain could act as a competitive inhibitor of the A-B interaction. There appears to be substantial structural alterations in both A and B in response to phosphorylation, as monitored by their acquisition of protease sensitivity after phosphorylation, suggesting that simple competitive inhibition by the C-terminal region may not be sufficient to explain the disruption of the A-B interaction.
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